1[1]Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet, 1993, 352 (8885):1441
2[2]Australia and New Zealand Heart Failure Research Collaborative Group. Randonised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease. Lancet, 1997,349(9024):375
3[3]Evans PH. Sweeney K. Keenan H, et al. Benefit of β-blockers for heart failure. Lancet, 1999,354: 682
8[9]McConnaughey MM, McConnaughey TS, Ingenito AT. Practical consideration of the pharmacology of angiotensin receptor. J Clin Pharmacol, 1999,39(6) :547
9[11]Brica G. Human brain imidazoline receptors: further characterzation with [3H] clonidine. Eur J Pharmacol, 1994,266( 1 ) :26
10[12]Ernsberger P. Selective antihypertensive action of moxnonidine is mediated mainly by I1-imidazoline sites. J Pharmacol Exp Ther, 1993,264(Ⅰ):172
